These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 13978785)

  • 1. Iothalamate (Conray, Angio-Conray), a new cardiovascular contrast agent of low toxicity, low viscosity and high opacity.
    STRAUBE KR; DOTTER CT
    J Cardiovasc Surg (Torino); 1963 Jun; 4():400-2. PubMed ID: 13978785
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON NEW CONTRAST MEDIA FOR INTRAVENOUS INJECTION; CONRAY AND ANGIO-CONRAY].
    OHKOSHI M; NAMAKAME Y; FUJIMURA S; KUDO S
    Rinsho Hoshasen; 1964 Jul; 9():547-57. PubMed ID: 14198875
    [No Abstract]   [Full Text] [Related]  

  • 3. SODIUM IOTHALAMATE, ANGIO-CONRAY, IN SELECTIVE ANGIOGRAPHY: FURTHER EVIDENCE OF LOW TOXICITY.
    MUDD JG; WILLMAN VL
    Am J Roentgenol Radium Ther Nucl Med; 1963 Dec; 90():1287-9. PubMed ID: 14081438
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the nephrotoxicity of iothalamate containing contrast media (conray, angio-conray) by means of experimental renal angiographies].
    Lélek I; Pokorny L
    Fortschr Geb Rontgenstr Nuklearmed; 1967 Feb; 106(2):247-55. PubMed ID: 5626681
    [No Abstract]   [Full Text] [Related]  

  • 5. CLINICAL EXPERIENCE WITH SODIUM IOTHALAMATE-80 PER CENT (ANGIO-CONRAY) IN CINEANGIOCARDIOGRAPHY.
    LINHART JW; WHALEN RE; MCINTOSH HD
    South Med J; 1965 Jun; 58():793-6. PubMed ID: 14294160
    [No Abstract]   [Full Text] [Related]  

  • 6. Angio-Conray: a new angiographic contrast agent.
    KANICK V; FINBY N
    Radiology; 1963 Mar; 80():438-43. PubMed ID: 13962235
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental studies of angio-conray: a new angiographic agent.
    BERNSTEIN EF; RELLER CR; GRAGE TB
    Radiology; 1962 Sep; 79():389-94. PubMed ID: 13868264
    [No Abstract]   [Full Text] [Related]  

  • 8. The old and the new: a study of five contrast media for urography.
    Davies P; Panto PN; Buckley J; Richardson RE
    Br J Radiol; 1985 Jul; 58(691):593-7. PubMed ID: 3893610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CLINICAL EVALUATION OF TWO NEW CONTRAST MEDIA: CONRAY AND ANGIO-CONRAY; APPLICATION TO THE RAPID-SEQUENCE INTRAVENOUS PYELOGRAPHY AND THE TRANSLUMBAR AORTOGRAPHY].
    KUSUNOKI T; ISOBE Y
    Hinyokika Kiyo; 1964 Sep; 10():635-40. PubMed ID: 14227902
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast agent induced thrombophlebitis following leg phlebography: iopamidol versus meglumine iothalamate.
    Lea Thomas M; Keeling FP; Piaggio RB; Treweeke PS
    Br J Radiol; 1984 Mar; 57(675):205-7. PubMed ID: 6365232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental evaluation of renal and spinal cord tolerance to a new angiographic agent, Angio-Conray.
    BERNSTEIN EF; MACKEY GC; EMMINGS FG; AMPLATZ K
    Surgery; 1962 May; 51():663-7. PubMed ID: 13868263
    [No Abstract]   [Full Text] [Related]  

  • 12. A SEVERE REACTION TO ANGIO-CONRAY.
    LAMPE WT
    Radiology; 1964 Mar; 82():456-8. PubMed ID: 14127174
    [No Abstract]   [Full Text] [Related]  

  • 13. NEW CARDIOVASCULAR CONTRAST MEDIA: SODIUM IOTHALAMATE (ANGIOCONRAY) AND METHYLGLUCAMINE IOTHALAMATE (CONRAY). COMPARATIVE OBSERVATIONS ON VARIOUS CONTRAST MEDIA IN ANGIOCARDIOGRAPHY.
    GRAINGER RG
    Br J Radiol; 1964 Aug; 37():568-80. PubMed ID: 14204528
    [No Abstract]   [Full Text] [Related]  

  • 14. CLINICAL EVALUATION OF SODIUM IOTHALAMATE 66.8 PER CENT (CONRAY-400).
    MARSHALL TR; LING JT; BUCHANAN J
    Am J Roentgenol Radium Ther Nucl Med; 1964 Sep; 92():676-81. PubMed ID: 14217086
    [No Abstract]   [Full Text] [Related]  

  • 15. NOTE ON INTRAVENOUS PYELOGRAPHY WITH 66.8 PER CENT SODIUM IOTHALAMATE; CONRAY-400, IODINE CONTENT 40 PER CENT.
    STEINBERG I; EVANS JA
    Am J Roentgenol Radium Ther Nucl Med; 1964 Aug; 92():267-9. PubMed ID: 14207569
    [No Abstract]   [Full Text] [Related]  

  • 16. CLINICAL EVALUATION OF CONRAY FOR ANGIOGRAPHY IN PATIENTS WITH CEREBROVASCULAR DISEASE.
    WEIBEL J; FIELDS WS; CRAWFORD ES; DEBAKEY ME; BEALL AC
    Am J Roentgenol Radium Ther Nucl Med; 1963 Dec; 90():1281-6. PubMed ID: 14081437
    [No Abstract]   [Full Text] [Related]  

  • 17. MULTIPLE-INJECTION TOXICITY OF ANGIO-CONRAY.
    RHEA WG; SESSIONS RT; KILLEN DA; FOSTER JH
    Surgery; 1964 Jun; 55():831-6. PubMed ID: 14168006
    [No Abstract]   [Full Text] [Related]  

  • 18. [The radiological demonstration of intra-cranial masses with intra-ventricular iothalamate (Conray)].
    Knoetgen I; Schwarz G; Argyropoulos G
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Jun; 116(6):751-5. PubMed ID: 4340392
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastro-Conray does not alter resting lower oesophageal sphincter pressure in normal human subjects.
    Brock-Utne JG; Dimopoulos GE; Downing JW; Moshal MG
    S Afr Med J; 1982 Jan; 61(1):22-3. PubMed ID: 7058396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RELATIVE NEPHROTOXICITY OF HYPAQUE AND ANGIO-CONRAY.
    RHEA WG; KILLEN DA; FOSTER JH
    Surgery; 1965 Apr; 57():554-8. PubMed ID: 14275783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.